Our Products

Lidocaine

Short Description:

Product Description Product name:lidocaine Exact mass:234.173218 Density:1.0¡À0.1 g/cm3 PSA:32.34000 Boiling point:372.7¡À52.0 ¡ãC at 760 mmHg LogP:3.63 Melting point:66-69¡ãC Appearence:White crystalline powder Molecular formula:C14H22N2O Vapour pressure:0.0¡À0.9 mmHg at 25¡ãC Molecular weight:234.337 Refractive index: 1.512 Flash point:179.2¡À30.7 ¡ãC Storage:cool and dry Lidocaine is a local anesthetic, also known as cerocain. In recent years


  • MOQ: 10g
  • Package:
  • Brand: QCLY
  • Payment terms: T/T,Bitcoin,western union,Paypal and so on
  • Shipping way: By air or sea
  • :
  • Product Detail

    Product Description

    Product name:lidocaineExact mass:234.173218
    Density:1.0¡À0.1 g/cm3PSA:32.34000
    Boiling point:372.7¡À52.0 ¡ãC at 760 mmHgLogP:3.63
    Melting point:66-69¡ãCAppearence:White crystalline powder
    Molecular formula:C14H22N2OVapour pressure:0.0¡À0.9 mmHg at 25¡ãC
    Molecular weight:234.337Refractive index: 1.512
    Flash point:179.2¡À30.7 ¡ãCStorage:cool and dry

    Lidocaine is a local anesthetic, also known as cerocain. In recent years, it has replaced procaine and is widely used in aesthetic plastic surgery for local infiltration anesthesia. It blocks nerve excitation and conduction by inhibiting the sodium ion channel of nerve cell membrane.
    Its lipid solubility and protein binding rate are all higher than that of Procaine, and it has strong cell-penetrating ability, fast effect, long action time and 4 times of the action intensity of procaine.
    Clinical applications include infiltration anesthesia, epidural anesthesia, topical anesthesia (including mucosal anesthesia for thoracoscopy or abdominal surgery), and nerve block.
    In order to prolong the time of anesthesia, reduce the toxic side effects of lidocaine, epinephrine can be added in anesthetics.
    Lidocaine can also be used to treat premature ventricular beats, ventricular tachycardia, digitalis poisoning, cardiac surgery and ventricular arrhythmias caused by cardiac catheters after acute myocardial infarction, including premature ventricular beats, ventricular tachycardia and ventricular fibrillation.
    Secondly, it is also used for epileptic status in patients who have failed to respond to other anticonvulsants and for local or intraspinal anesthesia.
    But it is usually ineffective against supraventricular arrhythmia.


  • Previous: none
  • Next: